Novavax（NASDAQ:NVAX）报告季度每股亏损0.51美元，与分析师的共识预期一致。与去年同期每股亏损1.47美元相比，这一数字增加了65.31%。该公司报告季度销售额为8831万美元，超过了分析师共识预期的8438万美元，增幅为4.66%。与去年同期的销售额2.9134亿美元相比，这一数字下降了69.69%。
以上内容来自Benzinga Earnings专栏，原文如下：
Novavax (NASDAQ:NVAX) reported quarterly losses of $(0.51) per share which met the analyst consensus estimate. This is a 65.31 percent increase over losses of $(1.47) per share from the same period last year. The company reported quarterly sales of $88.31 million which beat the analyst consensus estimate of $84.38 million by 4.66 percent. This is a 69.69 percent decrease over sales of $291.34 million the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。